Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Iloprost for PH After CHD Repair
NCT01310751Phase 3Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Jan 2011
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of iloprost in pulmonary hypertension (PH), sponsored by Shanghai Jiao Tong University School of Medicine. Started Jan 2011; status: completed.
02
Drugs
iloprost
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT01310751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01310751.